Ravi Thadhani

43.4k total citations · 15 hit papers
293 papers, 30.6k citations indexed

About

Ravi Thadhani is a scholar working on Nephrology, Pediatrics, Perinatology and Child Health and Pathology and Forensic Medicine. According to data from OpenAlex, Ravi Thadhani has authored 293 papers receiving a total of 30.6k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Nephrology, 82 papers in Pediatrics, Perinatology and Child Health and 80 papers in Pathology and Forensic Medicine. Recurrent topics in Ravi Thadhani's work include Vitamin D Research Studies (74 papers), Pregnancy and preeclampsia studies (68 papers) and Dialysis and Renal Disease Management (64 papers). Ravi Thadhani is often cited by papers focused on Vitamin D Research Studies (74 papers), Pregnancy and preeclampsia studies (68 papers) and Dialysis and Renal Disease Management (64 papers). Ravi Thadhani collaborates with scholars based in United States, Canada and Germany. Ravi Thadhani's co-authors include S. Ananth Karumanchi, Myles Wolf, Joseph V. Bonventre, Hector Tamez, Richard J. Levine, Julia Wenger, Manuel Pascual, Cong Qian, Benjamin Sachs and J. Michael Lazarus and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Ravi Thadhani

293 papers receiving 29.7k citations

Hit Papers

Circulating Angiogenic Fa... 1996 2026 2006 2016 2004 2002 2006 2008 1996 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Circulating Angiogenic Factors and the Risk of Preeclampsia
    2004 2.7k citations Richard J. Levine, Cong Qian et al. profile →
  2. Kidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury
    2002 1.4k citations Ravi Thadhani et al. Kidney International profile →
  3. Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia
    2006 1.4k citations Richard J. Levine, Chun Sing Lam et al. profile →
  4. Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
    2008 1.3k citations Orlando M. Gutiérrez, Hector Tamez et al. profile →
  5. Acute Renal Failure
    1996 1.1k citations Ravi Thadhani et al. profile →
  6. Hypovitaminosis D in Medical Inpatients
    1998 1.1k citations Ravi Thadhani et al. profile →
  7. Vitamin D–Binding Protein and Vitamin D Status of Black Americans and White Americans
    2013 786 citations Camille E. Powe, Julia Wenger et al. profile →
  8. Pre-eclampsia: pathogenesis, novel diagnostics and therapies
    2019 741 citations Ravi Thadhani, S. Ananth Karumanchi et al. profile →
  9. Prevalence of Cardiovascular Risk Factors and the Serum Levels of 25-Hydroxyvitamin D in the United States
    2007 677 citations Myles Wolf, Ravi Thadhani et al. profile →
  10. Survival of Patients Undergoing Hemodialysis with Paricalcitol or Calcitriol Therapy
    2003 673 citations Ming Teng, Myles Wolf et al. profile →
  11. Vitamin D levels and early mortality among incident hemodialysis patients
    2007 612 citations Myles Wolf, Anand Shah et al. Kidney International profile →
  12. Activated Injectable Vitamin D and Hemodialysis Survival
    2005 589 citations Ming Teng, Myles Wolf et al. Journal of the American Society of Nephrology profile →
  13. Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia
    2012 491 citations Sarosh Rana, Camille E. Powe et al. Circulation profile →
  14. Effects of Phosphate Binders in Moderate CKD
    2012 377 citations Andrew N. Hoofnagle, Ravi Thadhani et al. Journal of the American Society of Nephrology profile →
  15. Calciphylaxis
    2018 239 citations Sagar U. Nigwekar, Ravi Thadhani et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ravi Thadhani 9.5k 9.1k 8.7k 7.8k 4.0k 293 30.6k
Myles Wolf 1.7k 0.2× 13.6k 1.5× 2.6k 0.3× 7.7k 1.0× 5.5k 1.4× 247 22.6k
S. Ananth Karumanchi 26.7k 2.8× 2.5k 0.3× 20.0k 2.3× 2.1k 0.3× 1.1k 0.3× 367 38.2k
Eberhard Ritz 884 0.1× 19.5k 2.1× 3.3k 0.4× 4.9k 0.6× 4.1k 1.0× 934 44.8k
Harry van Goor 1.5k 0.2× 3.6k 0.4× 1.3k 0.2× 1.4k 0.2× 1.2k 0.3× 626 27.0k
Jacob Selhub 2.5k 0.3× 1.2k 0.1× 3.8k 0.4× 1.2k 0.2× 2.9k 0.7× 382 37.7k
Peter Stenvinkel 509 0.1× 19.6k 2.1× 2.1k 0.2× 1.6k 0.2× 3.3k 0.8× 648 38.2k
Anders Larsson 1.2k 0.1× 3.1k 0.3× 1.0k 0.1× 1.0k 0.1× 1.2k 0.3× 592 16.2k
Franz Schaefer 435 0.0× 8.0k 0.9× 3.6k 0.4× 973 0.1× 1.3k 0.3× 417 17.8k
Lilach O. Lerman 779 0.1× 3.2k 0.3× 1.5k 0.2× 931 0.1× 1.1k 0.3× 674 29.6k
Frederick Van Lente 409 0.0× 16.2k 1.8× 2.1k 0.2× 2.0k 0.3× 1.7k 0.4× 92 37.6k

Countries citing papers authored by Ravi Thadhani

Since Specialization
Citations

This map shows the geographic impact of Ravi Thadhani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravi Thadhani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravi Thadhani more than expected).

Fields of papers citing papers by Ravi Thadhani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravi Thadhani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravi Thadhani. The network helps show where Ravi Thadhani may publish in the future.

Co-authorship network of co-authors of Ravi Thadhani

This figure shows the co-authorship network connecting the top 25 collaborators of Ravi Thadhani. A scholar is included among the top collaborators of Ravi Thadhani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravi Thadhani. Ravi Thadhani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lim, Kenneth, Matthew Nayor, Heather Burney, et al.. (2024). Impairment of Cardiovascular Functional Capacity in Mild-to-Moderate Kidney Dysfunction. Clinical Journal of the American Society of Nephrology. 19(12). 1547–1561. 3 indexed citations
2.
Winkelmayer­, Wolfgang C., Anthonie W.A. Lensing, Ravi Thadhani, et al.. (2024). A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis. Kidney International. 106(1). 145–153. 16 indexed citations
3.
Best, Cora M., Leila R. Zelnick, Kenneth E. Thummel, et al.. (2021). Serum Vitamin D: Correlates of Baseline Concentration and Response to Supplementation in VITAL-DKD. The Journal of Clinical Endocrinology & Metabolism. 107(2). 525–537. 10 indexed citations
4.
James, Kaitlyn E., Marie‐France Hivert, James B. Meigs, et al.. (2021). Physiological subtypes of gestational glucose intolerance and risk of adverse pregnancy outcomes. American Journal of Obstetrics and Gynecology. 226(2). 241.e1–241.e14. 18 indexed citations
5.
Eneanya, Nwamaka D., Norma J. Ofsthun, Franklin W. Maddux, et al.. (2020). Mortality and Hospitalizations among Sickle Cell Disease Patients with End-Stage Kidney Disease Initiating Dialysis. American Journal of Nephrology. 51(12). 995–1003. 7 indexed citations
6.
Allegretti, Andrew S., Maureen M. Achebe, Nwamaka D. Eneanya, et al.. (2019). Kidney Function Decline among Black Patients with Sickle Cell Trait and Sickle Cell Disease: An Observational Cohort Study. Journal of the American Society of Nephrology. 31(2). 393–404. 33 indexed citations
7.
Srivastava, Anand, Ragnar Pálsson, Arnaud D. Kazé, et al.. (2018). The Prognostic Value of Histopathologic Lesions in Native Kidney Biopsy Specimens: Results from the Boston Kidney Biopsy Cohort Study. Journal of the American Society of Nephrology. 29(8). 2213–2224. 122 indexed citations
8.
Sircar, Monica, Ivy A. Rosales, Martin K. Selig, et al.. (2018). Complement 7 Is Up-Regulated in Human Early Diabetic Kidney Disease. American Journal Of Pathology. 188(10). 2147–2154. 36 indexed citations
9.
Chan, Kevin E., Elazer R. Edelman, Julia Wenger, Ravi Thadhani, & Franklin W. Maddux. (2015). Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis. Circulation. 131(11). 972–979. 241 indexed citations
10.
Zoccali, Carmine, Vincenzo Panuccio, Rocco Tripepi, et al.. (2014). Paricalcitol and Endothelial Function in Chronic Kidney Disease Trial. Hypertension. 64(5). 1005–1011. 99 indexed citations
11.
Bentley–Lewis, Rhonda, Camille E. Powe, Elizabeth Ankers, et al.. (2014). Effect of Race/Ethnicity on Hypertension Risk Subsequent to Gestational Diabetes Mellitus. The American Journal of Cardiology. 113(8). 1364–1370. 44 indexed citations
12.
Cohen, Allison, Julia Wenger, Tamarra James‐Todd, et al.. (2013). The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes. Hypertension in Pregnancy. 33(1). 81–92. 45 indexed citations
13.
Kalim, Sahir, Clary B. Clish, Julia Wenger, et al.. (2013). A Plasma Long‐Chain Acylcarnitine Predicts Cardiovascular Mortality in Incident Dialysis Patients. Journal of the American Heart Association. 2(6). e000542–e000542. 107 indexed citations
14.
Rana, Sarosh, Camille E. Powe, Saira Salahuddin, et al.. (2012). Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia. Circulation. 125(7). 911–919. 491 indexed citations breakdown →
15.
Camargo, Carlos A., Tristram Ingham, Kristin Wickens, et al.. (2010). Cord-Blood 25-Hydroxyvitamin D Levels and Risk of Respiratory Infection, Wheezing, and Asthma. PEDIATRICS. 127(1). e180–e187. 419 indexed citations
16.
Kong, Juan, Gene Kim, Minjie Wei, et al.. (2010). Therapeutic Effects of Vitamin D Analogs on Cardiac Hypertrophy in Spontaneously Hypertensive Rats. American Journal Of Pathology. 177(2). 622–631. 81 indexed citations
17.
Wolf, Myles, Joseph R. Betancourt, Yuchiao Chang, et al.. (2008). Impact of Activated Vitamin D and Race on Survival among Hemodialysis Patients. Journal of the American Society of Nephrology. 19(7). 1379–1388. 135 indexed citations
18.
Levine, Richard J., Chun Sing Lam, Cong Qian, et al.. (2007). Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia. Obstetrical & Gynecological Survey. 62(2). 82–83. 177 indexed citations
19.
Chasan‐Taber, Lisa, Karen Smirnakis, Maya Frank Wolf, et al.. (2005). Post-Partum Diabetes Screening Among Women with a History of Gestational Diabetes Mellitus. Obstetrics and Gynecology. 106(6). 2 indexed citations
20.
Wolf, Myles, et al.. (2002). First Trimester Insulin Resistance and Subsequent Preeclampsia: A Prospective Study. The Journal of Clinical Endocrinology & Metabolism. 87(4). 1563–1568. 175 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Myles Wolf Breakdown of academic impact, for papers by S. Ananth Karumanchi Breakdown of academic impact, for papers by Eberhard Ritz Breakdown of academic impact, for papers by Harry van Goor Breakdown of academic impact, for papers by Jacob Selhub Breakdown of academic impact, for papers by Peter Stenvinkel Breakdown of academic impact, for papers by Anders Larsson Breakdown of academic impact, for papers by Franz Schaefer Breakdown of academic impact, for papers by Lilach O. Lerman Breakdown of academic impact, for papers by Frederick Van Lente
Rankless by CCL
2026